This session will introduce the fundamentals of pharmacogenomics—the study of how a patient’s genetic makeup influences their response to medications—and highlight its potential in clinical practice. Physicians will learn how integrating genetic insights into prescribing decisions can enhance drug efficacy, reduce adverse drug reactions, and support personalized treatment strategies. Learn how pharmacogenomics can empower healthcare providers to deliver more precise, patient-centered care through genomics-informed medicine.
Dr. Allison Faber serves as the Marketing Lead at Arcensus, bringing a strong background in research and diagnostic genetics. She earned her Ph.D. in Physiology from the Medical College of Wisconsin and completed postdoctoral research at the Max Delbrück Center for Molecular Medicine.